Vaccine
Canada awards CSL Seqirus with influenza pandemic vaccine contract
March 17, 2026Manufacturing and Production CSL Seqirus, Canada, Vaccine
CSL Seqirus has been awarded a contract committing it to manufacturing and delivering influenza vaccines to support the Public Health …
BioNet receives positive EMA opinion on new pertussis vaccine
November 19, 2025Research and Development BioNet, Vaccine
BioNet has received a positive opinion from the Committee for Medicinal Products for Human Use of the European Medicines Agency …
Recipharm offers manufacturing support to vaccine trial from ImmBIO and iiCON
October 21, 2025Manufacturing and Production ImmunBiology, Infection Innovation Consortium, Recipharm, Vaccine, pneumococcal disease
Recipharm, a contract development and manufacturing organisation (CDMO), has successfully manufactured PnuBioVax, a new protein-based vaccine against pneumococcal disease, developed …
EMA lifts temporary ban on chikungunya vaccine Ixchiq following safety review
July 18, 2025Medical Communications Committee for Medicinal Products for Human USE, European Medicines Agency (EMA), Ixchiq, Pharmacovigilance Risk Assessment Committee (PRAC), Vaccine, Virology, chikungunya
After completing a safety review of Ixchiq – a vaccine for chikungunya – the European Medicines Agency’s (EMA) safety committee …
FDA approves Moderna’s Spikevax for children at increased risk of COVID-19
July 16, 2025Medical Communications COVID-19, Spikevax, US Food and Drug Administration, Vaccine, Virology
Moderna has been granted US Food and Drug Administration (FDA) approval for its COVID-19 vaccine, Spikevax, in children aged six …
Osivax publishes positive results from trial of influenza vaccine candidate
July 15, 2025Research and Development Osivax, Vaccine, Virology, clinical trial, influenza, respiratory diseases
French biopharma, Osivax, has announced positive results from its phase 2 study, OVX836-004, into OVX836, its broad-spectrum influenza vaccine lead …
Osivax reaches key milestone in phase 2a trial for broad-spectrum flu vaccine
June 6, 2025Research and Development Ghent University Hospital, Osivax, Vaccine, Virology, clinical trial, influenza a
Osivax has announced the completion of patient visits in its phase 2a trial evaluating a booster dose of OVX836, a …
HIV vaccine candidate successfully optimised for industrial production
October 30, 2024Research and Development HIV, HIV/AIDS, Naobios, Sumagen, Vaccine, agreement
Sumagen Canada Inc, a biotech company based in both South Korea and Canada has partnered with CDMO Naobios to industrialise …
ILiAD Biotechnologies announces collaboration with Emmes Group on phase 3 pertussis vaccine trial
June 25, 2024Research and Development Emmes Group, ILiAD Biotechnologies, Infections and infestations, Vaccine, whooping cough
ILiAD Biotechnologies has announced that it has selected Emmes Group to conduct the upcoming phase 3 trials of its lead …
GSK’s Arexvy vaccine approved by FDA for RSV prevention in adult patients
June 10, 2024Medical Communications FDA, GSK, Immunology, Vaccine
GSK has announced that the US Food and Drug Administration (FDA) has approved Arexvy (Respiratory Syncytial Virus (RSV) Vaccine, Adjuvanted) …
Moderna shares update on RSV vaccine
May 13, 2024Medical Communications FDA, Immunology, Moderna, Vaccine
Moderna has announced that the US Food and Drug Administration (FDA) has shared that it will not complete its review …
GSK shares new data for RSV vaccine Arexvy
October 25, 2023Research and Development Arexvy, GSK, Immunology, RSV, Vaccine
GSK announced positive results from its phase 3 trial which assessed the immune response and safety of Arexvy, its respiratory …
GSK and Zhifei partner for shingles vaccine promotion in China
October 9, 2023Medical Communications GSK, Immunology, Shingrix, Vaccine, Zhifei, shingles
GSK has announced that it has come to an exclusive agreement with Chingqing Zhifei Biological Products to co-promote GSK’s shingles …
WHO recommends new vaccine for prevention of malaria in children
October 3, 2023Medical Communications Immunology, Vaccine, WHO, malaria, malaria vaccine
The World Health Organization (WHO) has announced that it has recommended a new vaccine, R21/Matrix-M, for the prevention of malaria …
Vaxart shares topline data from phase 2 study of norovirus vaccine candidate
September 8, 2023Research and Development Infections and infestations, Vaccine, Vaxart, norovirus
Vaxart has announced topline data from its phase 2 challenge study which assessed its oral tablet monovalent norovirus vaccine candidate. …
Latest content
FibroFind appoints Lee Borthwick as CEO
